In addition, the direct association of EpCAM with the progression of ovarian cancer suggested that it may serve as potential therapeutic target for the treatment of ovarian cancer and different approaches have been established to target EpCAM [26], [27]. This evidence concerns the gene EPCAM and ovarian carcinoma.